|
Genital warts (men) [11]
|
NA
|
136.60
|
31,163 (30,806–31,497)
|
|
Genital warts (women) [11]
|
NA
|
99.60
|
23,560 (23,238–23,839)
|
|
CIN 2/3 [13,15]
|
NA
|
142.02
|
33,594 (33,235–33,953)
|
|
VIN2/3 [13,15]
|
NA
|
6.02
|
1424 (1350–1498)
|
|
VaIN 2/3 [13,15]
|
NA
|
1.02
|
241 (210–271)
|
|
AIN 2/3 (men) [13, 16]
|
NA
|
0.57
|
130 (108–153)
|
|
AIN 2/3 (women) [13, 16]
|
NA
|
0.27
|
63 (47–78)
|
|
PIN 2/3 [13, 17]
|
NA
|
1.32
|
302 (268–336)
|
|
Cervical cancer [13]
|
C53
|
10.10
|
2389 (2293–2485)
|
|
Vulvar cancer [12, 13]
|
C51
|
2.77
|
655 (556–754)
|
|
Vaginal cancer [12, 13]
|
C52
|
0.47
|
111 (70–151)
|
|
Anal cancer (men) [12, 13]
|
C21
|
0.86
|
197 (143–250)
|
|
Anal cancer (women) [12, 13]
|
C21
|
0.68
|
160 (111–209)
|
|
Penile cancer [12, 13]
|
C60
|
1.91
|
436 (356–516)
|
|
Oral cavity cancer (men) [12, 13]
|
C02–06
|
7.55
|
1724 (1492–1955)
|
|
Oral cavity cancer (women) [12, 13]
|
C02–06
|
0.64
|
736 (574–876)
|
|
Nasopharynx cancer (men) [12, 13]
|
C11
|
1.54
|
352 (277–426)
|
|
Nasopharynx cancer (women) [12, 13]
|
C11
|
0.45
|
106 (65–148)
|
|
Oropharynx cancer (men) [12, 13]
|
C01, C09, C10
|
1.64
|
1066 (841–1290)
|
|
Oropharynx cancer (women) [12, 13]
|
C01, C09, C10
|
0.10
|
152 (68–233)
|
|
Hypopharynx cancer (men) [12, 13]
|
C12–13
|
3.62
|
826 (711–940)
|
|
Hypopharynx cancer (women) [12, 13]
|
C12–13
|
0.25
|
59 (28–89)
|
|
Pharynx cancer (men) [12, 13]
|
C14
|
1.05
|
240 (179–302)
|
|
Pharynx cancer (women) [12, 13]
|
C14
|
0.13
|
32 (9–54)
|
|
Larynx cancer (men) [12, 13]
|
C32
|
16.72
|
3815 (3569–4060)
|
|
Larynx cancer (women) [12, 13]
|
C32
|
0.92
|
217 (158–276)
|
